PL2201002T3 - Antagoniści receptora 5-HT7 - Google Patents

Antagoniści receptora 5-HT7

Info

Publication number
PL2201002T3
PL2201002T3 PL08836911T PL08836911T PL2201002T3 PL 2201002 T3 PL2201002 T3 PL 2201002T3 PL 08836911 T PL08836911 T PL 08836911T PL 08836911 T PL08836911 T PL 08836911T PL 2201002 T3 PL2201002 T3 PL 2201002T3
Authority
PL
Poland
Prior art keywords
receptor antagonists
migraine
formula
treatment
present
Prior art date
Application number
PL08836911T
Other languages
English (en)
Inventor
Valentina O Badescu
Sandra Ann Filla
Peter Thaddeus Gallagher
Maria Ann Whatton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PL2201002T3 publication Critical patent/PL2201002T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08836911T 2007-10-12 2008-09-30 Antagoniści receptora 5-HT7 PL2201002T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97946407P 2007-10-12 2007-10-12
PCT/US2008/078294 WO2009048765A1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists
EP08836911A EP2201002B1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists

Publications (1)

Publication Number Publication Date
PL2201002T3 true PL2201002T3 (pl) 2012-07-31

Family

ID=40134870

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08836911T PL2201002T3 (pl) 2007-10-12 2008-09-30 Antagoniści receptora 5-HT7

Country Status (19)

Country Link
US (1) US7910588B2 (pl)
EP (1) EP2201002B1 (pl)
JP (1) JP5291716B2 (pl)
KR (1) KR101161070B1 (pl)
CN (1) CN101821257B (pl)
AT (1) ATE548365T1 (pl)
AU (1) AU2008311154B2 (pl)
BR (1) BRPI0818450A2 (pl)
CA (1) CA2699674C (pl)
CY (1) CY1112709T1 (pl)
DK (1) DK2201002T3 (pl)
EA (1) EA016787B1 (pl)
ES (1) ES2380756T3 (pl)
HR (1) HRP20120257T1 (pl)
MX (1) MX2010003986A (pl)
PL (1) PL2201002T3 (pl)
PT (1) PT2201002E (pl)
SI (1) SI2201002T1 (pl)
WO (1) WO2009048765A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396857B (zh) * 2009-12-30 2013-05-21 Etron Technology Inc 晶片測試電路
KR20140075783A (ko) 2011-10-11 2014-06-19 유씨비 파마, 에스.에이. 2­옥소­피페리디닐 유도체
US9802924B2 (en) 2013-03-11 2017-10-31 Temple University Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
TW201601632A (zh) * 2013-11-20 2016-01-16 杜邦股份有限公司 １－芳基－３－烷基吡唑殺蟲劑
EP3200589A4 (en) 2014-09-10 2018-07-25 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
KR20230148384A (ko) 2016-11-15 2023-10-24 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 5-히드록시트립타민 수용체 7의 신규 조절제 및 이의 사용 방법
EP3600289A4 (en) 2017-03-21 2020-08-05 Temple University - Of The Commonwealth System of Higher Education 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US20030008880A1 (en) 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
EP1592772A2 (en) * 2003-01-31 2005-11-09 Pfizer Products Incorporated 5ht7 antagonists and inverse agonists
US7211783B2 (en) 2004-01-09 2007-05-01 Tamperproof Container Licensing Corp. Tamper-proof container
AU2005249494A1 (en) 2004-05-28 2005-12-15 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
TW200914020A (en) * 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Also Published As

Publication number Publication date
US7910588B2 (en) 2011-03-22
ES2380756T3 (es) 2012-05-18
CA2699674C (en) 2013-07-16
WO2009048765A1 (en) 2009-04-16
BRPI0818450A2 (pt) 2015-05-12
EP2201002B1 (en) 2012-03-07
CA2699674A1 (en) 2009-04-16
AU2008311154B2 (en) 2013-09-26
KR101161070B1 (ko) 2012-07-13
US20100197700A1 (en) 2010-08-05
CN101821257A (zh) 2010-09-01
EA016787B1 (ru) 2012-07-30
ATE548365T1 (de) 2012-03-15
JP5291716B2 (ja) 2013-09-18
CY1112709T1 (el) 2016-02-10
EA201070462A1 (ru) 2010-10-29
JP2011500575A (ja) 2011-01-06
SI2201002T1 (sl) 2012-04-30
HRP20120257T1 (hr) 2012-04-30
EP2201002A1 (en) 2010-06-30
CN101821257B (zh) 2013-05-22
KR20100054853A (ko) 2010-05-25
AU2008311154A1 (en) 2009-04-16
PT2201002E (pt) 2012-04-27
DK2201002T3 (da) 2012-04-10
MX2010003986A (es) 2010-04-27

Similar Documents

Publication Publication Date Title
MY165113A (en) Piperidinone carboxamide azaindane cgrp receptor antagonists
JO2355B1 (en) Hereditary calcitonin polypeptide receptor antagonists
BRPI0514736A (pt) inibidores do receptor sigma
EP1608627A4 (en) BICYCLIC ANILID SPIROHYDANTOINS AS CGRP RECEPTOR ANTAGONISTS
EP1861399A4 (en) CGRP RECEPTOR ANTAGONISTS
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
UA105911C2 (uk) Сульфонамідні похідні
TW200608960A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
MX338489B (es) Derivados de hidantoina utiles como inhibidores de kv3.
EP1606264A4 (en) ANTAGONISTS OF MONOCYCLIC SPIROHYDANTOIN ANILIDE CGRP RECEPTORS
EP1606286A4 (en) BENZODIAZEPINE SPIROHYDANTOINES AS CGRP RECEPTOR ANTAGONISTS
IL182317A0 (en) Cgrp receptor antagonists
CY1112709T1 (el) Ανταγωνιστες υποδοχεα 5-ητ7
TN2011000171A1 (en) Isonicotinamide orexin receptor antagonists
NZ590650A (en) Buprenorphine analogs
MX2009004745A (es) Derivados de 1,2,3-triazol como inhibidores del receptor sigma.
TW200734323A (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors
MY147649A (en) Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders
ATE542795T1 (de) Benzylpiperazinderivate als motilin- rezeptorantagonisten
EP1856100A4 (en) CGRP RECEPTOR ANTAGONISTS
DE602005027870D1 (de) Cgrp-rezeptorantagonisten
EA201101207A1 (ru) Применение антагонистов рецептора nk
MX2012007005A (es) Tiazoles biciclicos como moduladores alostericos de recptores de glutamato metabotropico subtipo 5.
EA200802104A1 (ru) Применение композиций, содержащих антагонисты каппа-опиоидных рецепторов, для лечения диссоциативных расстройств
DE60306138D1 (de) Azaindolylpiperidinderivate als antihistaminika und antiallergika